Brief: Creative Medical Technology Holdings Develops Allostem Clinical Cell Line
20/10/2022 13:33
Oct 20 (Reuters) - Creative Medical Technology Holdings
Inc CELZ.O :
* CREATIVE MEDICAL TECHNOLOGY HOLDINGS DEVELOPS ALLOSTEM™
CLINICAL
CELL LINE
* CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC - ALLOGENIC CELL
LINE
TO BE SUBMITTED FOR FDA REGISTRATION
Source text for Eikon: ID:nPn6Rdd91a
Further company coverage: CELZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Buys 4 Million Biodefense Shares For $200,000 Cash And 1 Million Shares On Sept 24
Brief: Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM